Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHZ2500095	布地奈德福莫特罗吸入粉雾剂(II)	budesonide;formoterol fumarate	Inhalation	Chemical Drugs	License Renew	2025-04-23		AstraZeneca AB;Astrazeneca Investment (China) Co Ltd			view
JYHZ2300381	布地奈德福莫特罗吸入粉雾剂(II)	budesonide;formoterol fumarate	Inhalation	Chemical Drugs	License Renew	2023-09-15		AstraZeneca AB;Astrazeneca Investment (China) Co Ltd			view
JYHZ2300380	布地奈德福莫特罗吸入粉雾剂(II)	budesonide;formoterol fumarate	Inhalation	Chemical Drugs	License Renew	2023-09-15		AstraZeneca AB;Astrazeneca Investment (China) Co Ltd			view
JXHS1900174	布地奈德福莫特罗吸入粉雾剂(II)	budesonide;formoterol fumarate	Inhalation	Chemical Drugs(5.1)	Import Drug Application	2020-01-08	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd;AstraZeneca AB	Certificate Issued	2021-01-21	view
JXHS1900173	布地奈德福莫特罗吸入粉雾剂(II)	budesonide;formoterol fumarate	Inhalation	Chemical Drugs(5.1)	Import Drug Application	2020-01-08	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd;AstraZeneca AB	Certificate Issued	2021-01-21	view